APA (7th ed.) Citation

Zhang, J., Li, K., Sun, H., Sun, S., Zhu, Y., Ge, Y., . . . Han, X. (2023). The heparan sulfate mimetic Muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase. British Journal of Pharmacology, 180(14), 1803. https://doi.org/10.1111/bph.16047

Chicago Style (17th ed.) Citation

Zhang, Jia, et al. "The Heparan Sulfate Mimetic Muparfostat Aggravates Steatohepatitis in Obese Mice Due to Its Binding Affinity to Lipoprotein Lipase." British Journal of Pharmacology 180, no. 14 (2023): 1803. https://doi.org/10.1111/bph.16047.

MLA (9th ed.) Citation

Zhang, Jia, et al. "The Heparan Sulfate Mimetic Muparfostat Aggravates Steatohepatitis in Obese Mice Due to Its Binding Affinity to Lipoprotein Lipase." British Journal of Pharmacology, vol. 180, no. 14, 2023, p. 1803, https://doi.org/10.1111/bph.16047.